Special Issue "Andrology and Reproductive Health"
A special issue of Uro (ISSN 2673-4397).
Deadline for manuscript submissions: 31 December 2023 | Viewed by 2234
Interests: andrology; biofilm; bladder cancer; bph; functional urology; nutraceuticals and phytotherapy; prostate cancer; penile cancer; urinary tract infections; mini-invasive surgery
Special Issues, Collections and Topics in MDPI journals
Several decades ago, it was almost impossible to even imagine the progress that we have seen today in andrology and reproductive health. As you well know, the modern history of andrology is strictly associated to the discovery of sildenafil. Since March 1998, when sildenafil became available in the United States, we have had new PDE5-is drugs, and the amount of research has increased in the andrological field. Technical innovations, new drugs, and new insights in the pathophysiology of andrological disease have also improved our knowledge in the field of reproductive health. With respect to andrology and reproductive health, we have recently taken a giant step forward, but there are some grey zones: developing new diagnostic tools, new management strategies in infertile men, and the influence of factors on semen quality such as air pollution, the use of pesticides, and harmful chemicals. Evidently, andrology and reproductive health are rapidly evolving sciences. In this Special Issue, we wish to discuss the newest findings concerning the grey zones in andrology and reproductive health, giving readers useful tools for everyday clinical practice. Key areas of this Special Issue include but are not limited to andrology, erectile dysfunction, precox ejaculation, hormone stimulation, hypogonadism, male infertility, testicular sperm extraction, and varicocele. Moreover, special attention will be given to the psychological impact of andrological diseases and the role of partners. We hope to give readers an interesting and multidisciplinary tool for use in everyday clinical practice and to invite many colleagues to focus part of their clinical research in the field of andrology and reproductive health.
Prof. Dr. Tommaso Cai
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Uro is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.